Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 281

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis

Open access
Xu, Jian-Zhen, Shao, Chang-Chun, Wang, Xiao-Jia, Zhao, Xing, Chen, Jun-Qing, Ouyang, Yan-Xiu, Feng, Jun, Zhang, Fan, Huang, Wen-He, Ying, Qian, Chen, Chun-Fa, Wei, Xiao-Long, Dong, Hong-Yan, Zhang, Guo-Jun, Chen, Min·2019·Cell Death & Disease

Abstract

More and more evidence indicates that circular RNAs (circRNAs) have important roles in several diseases, especially in cancers. However, their involvement remains to be investigated in breast cancer. Through screening circRNA profile, we identified 235 differentially expressed circRNAs in breast cancer. Subsequently, we explored the clinical significance of two circTADA2As in a large cohort of triple-negative breast cancer (TNBC), and performed functional analysis of circTADA2A-E6 in vitro and in vivo to support clinical findings. Finally, we evaluated the effect of circTADA2A-E6 on miR-203a-3p and its target gene SOCS3. We detected two circRNAs, circTADA2A-E6 and circTADA2A-E5/E6, which were among the top five differentially expressed circRNAs in breast cancer. They were consistently and significantly decreased in a large cohort of breast cancer patients, and their downregulation was associated with poor patient survival for TNBC. Especially, circTADA2A-E6 suppressed in vitro cell proliferation, migration, invasion, and clonogenicity and possessed tumor-suppressor capability. circTADA2A-E6 preferentially acted as a miR-203a-3p sponge to restore the expression of miRNA target gene SOCS3, resulting in a less aggressive oncogenic phenotype. circTADA2As as promising prognostic biomarkers in TNBC patients, and therapeutic targeting of circTADA2As/miRNA/mRNA network may be a potential strategy for the treatment of breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-019-1382-y

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 52 references

Cited by

See all 281

Metadata

Authors
Xu, J.-Z., Shao, C.-C., Wang, X.-J., Zhao, X., Chen, J.-Q., Ouyang, Y.-X., Feng, J., Zhang, F., Huang, W.-H., Ying, Q., Chen, C.-F., Wei, X.-L., Dong, H.-Y., Zhang, G.-J., & Chen, M.
Venue
Cell Death & Disease
Published
2019-02-20
Volume
10
Issue
3
Pages
175-175
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2917544498
Cited by
281
References
52
FWCI
14.11
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. https://app.cochat.ai/papers/10.1038/s41419-019-1382-y
The paper
Xu, J.-Z., Shao, C.-C., Wang, X.-J., Zhao, X., Chen, J.-Q., Ouyang, Y.-X., Feng, J., Zhang, F., Huang, W.-H., Ying, Q., Chen, C.-F., Wei, X.-L., Dong, H.-Y., Zhang, G.-J., & Chen, M. (2019). circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death & Disease. https://doi.org/10.1038/s41419-019-1382-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.